MAFFEZZOLI, MICHELE
 Distribuzione geografica
Continente #
AS - Asia 702
NA - Nord America 681
EU - Europa 371
SA - Sud America 146
AF - Africa 44
OC - Oceania 2
Totale 1.946
Nazione #
US - Stati Uniti d'America 662
SG - Singapore 297
CN - Cina 158
IT - Italia 137
BR - Brasile 121
VN - Vietnam 88
HK - Hong Kong 75
DE - Germania 44
NL - Olanda 36
FR - Francia 30
GB - Regno Unito 29
ZA - Sudafrica 29
IN - India 24
IE - Irlanda 23
RU - Federazione Russa 18
AR - Argentina 14
KR - Corea 12
AT - Austria 11
SE - Svezia 11
BD - Bangladesh 9
CA - Canada 9
FI - Finlandia 8
JP - Giappone 7
MA - Marocco 7
IQ - Iraq 6
MX - Messico 6
PL - Polonia 6
ES - Italia 4
ID - Indonesia 4
MY - Malesia 4
CO - Colombia 3
EC - Ecuador 3
LT - Lituania 3
PH - Filippine 3
PK - Pakistan 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
AZ - Azerbaigian 2
BE - Belgio 2
BG - Bulgaria 2
CZ - Repubblica Ceca 2
EG - Egitto 2
KE - Kenya 2
PE - Perù 2
TN - Tunisia 2
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DZ - Algeria 1
EE - Estonia 1
GR - Grecia 1
HN - Honduras 1
IR - Iran 1
JM - Giamaica 1
KZ - Kazakistan 1
LV - Lettonia 1
PA - Panama 1
PS - Palestinian Territory 1
RS - Serbia 1
SA - Arabia Saudita 1
TH - Thailandia 1
TR - Turchia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 1.946
Città #
Singapore 176
Dallas 168
Ashburn 130
Santa Clara 75
Hong Kong 74
Beijing 45
Boardman 45
Ho Chi Minh City 38
Hefei 35
Johannesburg 28
Munich 25
Dublin 23
Milan 22
Los Angeles 21
Parma 18
Hanoi 15
Marseille 15
Modena 13
Shanghai 13
Buffalo 11
New York 11
Seoul 11
São Paulo 11
Brooklyn 9
Chennai 9
Bengaluru 8
Moscow 8
Denver 7
Nuremberg 7
Paris 7
Portsmouth 7
Rio de Janeiro 7
Tokyo 7
Columbus 6
Meknes 6
Orem 6
Poplar 6
Turku 6
Vienna 6
Amsterdam 5
Atlanta 5
Bologna 5
Council Bluffs 5
Stockholm 5
Da Nang 4
Houston 4
London 4
Montreal 4
Sungai Petani 4
Warsaw 4
Aachen 3
Bauru 3
Belo Horizonte 3
Brescia 3
Buenos Aires 3
Chicago 3
Düsseldorf 3
Frankfurt am Main 3
Genoa 3
Ninh Bình 3
Paderno Dugnano 3
Poços de Caldas 3
Quito 3
Salt Lake City 3
Scandiano 3
Tianjin 3
Ancona 2
Baghdad 2
Baku 2
Biên Hòa 2
Boston 2
Brussels 2
Busto Arsizio 2
Caxias do Sul 2
Curitiba 2
Dubai 2
Erbil 2
Felino 2
Foshan 2
Ha Long 2
Haiphong 2
Honolulu 2
Ivanovo 2
Jerago Con Orago 2
Lahore 2
Macaé 2
Manchester 2
Melbourne 2
Newark 2
Noida 2
North Bergen 2
Ottawa 2
Perugia 2
Phoenix 2
Ponta Grossa 2
Pune 2
Quezon City 2
Ribeirão Preto 2
Roubaix 2
San Francisco 2
Totale 1.300
Nome #
New hormonal agents and integrated strategies for non-metastatic, hormone-sensitive prostate carcinoma: the orphan setting?—a narrative review 151
Intersecting Blood Cytokines With Cholesterol Parameters to Profile Patients With Advanced Solid Tumors Receiving Immune Checkpoint Inhibitors 117
91 Circulating lipid profile as a prognostic factor in patients with advanced solid tumors treated with immune checkpoint inhibitors 106
The prognostic value of the haemoglobin/red cell distribution width ratio in a cohort of pre-treated patients with renal cell carcinoma receiving nivolumab 96
Real world analysis of peritoneal metastasis from renal cell carcinoma: Meet-Uro 27 study 93
The effect of concomitant drugs on oncological outcomes in patients treated with immunotherapy for metastatic urothelial carcinoma: a narrative review 93
Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario 90
Takotsubo syndrome in a patient with metastatic renal cell carcinoma treated with pembrolizumab plus axitinib 89
External Validation of the GRade, Age, Nodes and Tumor (GRANT) Score for Patients with Surgically Treated Papillary Renal Cell Carcinoma 87
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors 84
Differential impact of lipid profile according to neutrophil-to-lymphocyte ratio status in patients with advanced cancer treated with immunotherapy 82
Role of Hb to RDW ratio in metastatic renal cell carcinoma patients treated with first-line immunotherapy combinations 80
External validation of the GRade, Age, Nodes and Tumor (GRANT) score for patients with surgically treated papillary renal cell carcinoma. - Proceedings from the Second International Urology Cancer Summit, 27th September, Portsmouth, UK. 77
Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort Study 71
Real World Analysis of Peritoneal Metastasis From Renal Cell Carcinoma. Meet-Uro27 69
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study) 61
Prognostication for surgically treated papillary renal cell carcinoma: which model is the optimal choice? 61
External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations 58
The distinct prognostic impact of circulating lipid profile according to neutrophil to lymphocyte ratio in patients with advanced solid tumors treated with immune check point inhibitors. 55
Immunohistochemical (IHC) analyses of the immune tumor microenvironment (I-TME) in metastatic renal cell carcinoma (mRCC) patients (pts) receiving immunotherapy: secondary analyses of the Meet-URO 18 study 54
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study 54
Management of oligometastatic and oligoprogressive renal cell carcinoma: an updated review 51
Global Variations in Oncology Professionals' Confidence Levels for Managing Antibody-Drug Conjugate Toxicities: A Cross-Continental Survey 49
Use of concomitant proton pump inhibitors, statins, or metformin in patients treated with pembrolizumab for advanced urothelial carcinoma: data from the ARON-2 retrospective study. 48
Prognostic models for patients with metastatic urothelial carcinoma: why to use them? 47
The Role of Circulating Tumor DNA in Patients Treated with Adjuvant Immune Checkpoint Inhibitors: Clinical Reality or Distant Horizon? 39
Efficacy of Enfortumab Vedotin After Platinum Chemotherapy and Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Real-World Analysis of the ARON-2EV Cohort 12
Totale 1.974
Categoria #
all - tutte 6.778
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.778


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202361 0 0 0 0 11 2 5 1 27 0 15 0
2023/2024121 0 8 4 3 14 13 13 9 16 9 15 17
2024/2025648 7 36 44 35 69 69 38 49 55 57 59 130
2025/20261.144 154 156 328 199 249 58 0 0 0 0 0 0
Totale 1.974